Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Anupam Rasayan to acquire up to 43 pc stake in Bliss GVS Pharma for around Rs 1,369 cr
Specialty chemicals maker Anupam Rasayan India is set to acquire up to 43.3% of Bliss GVS Pharma for an estimated Rs 1,369.51 crore, with an open offer for an additional 26%. This strategic move aims to strengthen Anupam Rasayan's presence across the pharmaceutical value chain, from key starting materials to finished dosage formulations.
Five Stocks To Buy: Aurobindo Pharma, Tata Communications, Graphite India And More | May 18, 2026
Top picks include pharma majors Aurobindo Pharma and OneSource Specialty Pharma, agrochemical player Sumitomo Chemical India, telecom giant Tata Communications, and industrial manufacturing firm Graphite India.
Chennai Petroleum Corporation Ltd leads losers in 'A' group
Kaveri Seed Company Ltd, ITI Ltd, Mangalore Refinery And Petrochemicals Ltd and OneSource Specialty Pharma Ltd are among the other losers in the BSE's 'A' group today, 18 March 2026.
Dipan Mehta prefers pharma, specialty chemicals; stays cautious on IT, exits Info Edge
Dipan Mehta of Elixir Equities prefers pharma and specialty chemicals for medium-term investments, remains cautious on IT amid AI uncertainty, and suggests exiting Info Edge stock.